Navigation Links
After-Effects of Chemotherapy May Include Memory Problems
Date:9/23/2009

Lack of concentration, thinking difficulties reported by breast cancer survivors, researchers say

WEDNESDAY, Sept. 23 (HealthDay News) -- Chemotherapy can save the lives of people with cancer, but new research suggests it may have devastating effects on the brain.

Many cancer patients who receive chemotherapy report "chemobrain" -- a range of symptoms including a loss of memory and the ability to concentrate, and other problems such as difficulty thinking.

The stories of women who survived breast cancer but suffered from weakened brain power are told in a study published online Sept. 16 in the Journal of Cancer Survivorship.

Saskia Subramanian, from the Center for Culture and Health at the University of California -- Los Angeles, and colleagues interviewed 74 women who had completed cancer treatment at least a year earlier. The women described a variety of emotions, including fear, frustration and emotional exhaustion.

In some cases, women stated that they feared losing their independence because they wouldn't be able to take care of themselves like before. They sometimes devoted less time to work and to social activities, and felt that the medical community didn't pay enough attention to their symptoms of chemobrain, according to a news release about the study.

At the workplace, the side effects of chemotherapy robbed their ability to focus, potentially making it less likely that they'd be promoted, the study authors pointed out.

"These data underscore the very serious ways in which chemobrain can affect the life experiences of cancer survivors -- emotionally, psychologically and economically," the researchers concluded. "A clear understanding of the cognitive impairments experienced by survivors will aid researchers in developing targeted therapies and interventions aimed at improving or mitigating these post-treatment side effects."

More information

The American Cancer Society has more on chemobrain.



-- Randy Dotinga



SOURCE: Journal of Cancer Survivorship, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study
2. Yeast unravels effects of chemotherapy drugs
3. Chemotherapy Linked to Sleep-Wake Cycle Disruptions
4. Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women
5. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
6. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
7. Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option
8. Life after chemotherapy: Daily tasks, quality of life may be affected, MU researcher finds
9. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
10. Fluorescent probes may permit monitoring of chemotherapy effectiveness, Stanford study shows
11. Elderly breast cancer patients receive chemotherapy if treated in private practices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
After-Effects of Chemotherapy May Include Memory Problems
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: